135 related articles for article (PubMed ID: 2123232)
1. Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein A-I and B-100 kinetics.
Lichtenstein AH; Cohn JS; Hachey DL; Millar JS; Ordovas JM; Schaefer EJ
J Lipid Res; 1990 Sep; 31(9):1693-701. PubMed ID: 2123232
[TBL] [Abstract][Full Text] [Related]
2. Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding.
Cohn JS; Wagner DA; Cohn SD; Millar JS; Schaefer EJ
J Clin Invest; 1990 Mar; 85(3):804-11. PubMed ID: 2107210
[TBL] [Abstract][Full Text] [Related]
3. Measurement of human apolipoprotein B-48 and B-100 kinetics in triglyceride-rich lipoproteins using [5,5,5-2H3]leucine.
Lichtenstein AH; Hachey DL; Millar JS; Jenner JL; Booth L; Ordovas J; Schaefer EJ
J Lipid Res; 1992 Jun; 33(6):907-14. PubMed ID: 1512514
[TBL] [Abstract][Full Text] [Related]
4. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
5. Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia.
Elias N; Patterson BW; Schonfeld G
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2714-21. PubMed ID: 10559016
[TBL] [Abstract][Full Text] [Related]
6. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach.
Pietzsch J; Wiedemann B; Julius U; Nitzsche S; Gehrisch S; Bergmann S; Leonhardt W; Jaross W; Hanefeld M
J Lipid Res; 1996 Oct; 37(10):2074-87. PubMed ID: 8906585
[TBL] [Abstract][Full Text] [Related]
7. Production of apolipoprotein B-67 in apolipoprotein B-67/B-100 heterozygotes: technical problems associated with leucine contamination in stable isotope studies.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Ordovas JM; Schaefer EJ
J Lipid Res; 1997 Aug; 38(8):1535-43. PubMed ID: 9300775
[TBL] [Abstract][Full Text] [Related]
8. VLDL apolipoprotein B-100, a potential indicator of the isotopic labeling of the hepatic protein synthetic precursor pool in humans: studies with multiple stable isotopically labeled amino acids.
Reeds PJ; Hachey DL; Patterson BW; Motil KJ; Klein PD
J Nutr; 1992 Mar; 122(3):457-66. PubMed ID: 1542004
[TBL] [Abstract][Full Text] [Related]
9. The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.
Jenner JL; Seman LJ; Millar JS; Lamon-Fava S; Welty FK; Dolnikowski GG; Marcovina SM; Lichtenstein AH; Barrett PH; deLuca C; Schaefer EJ
Metabolism; 2005 Mar; 54(3):361-9. PubMed ID: 15736114
[TBL] [Abstract][Full Text] [Related]
10. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
[TBL] [Abstract][Full Text] [Related]
11. In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene.
Elias N; Patterson BW; Schonfeld G
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1309-15. PubMed ID: 10807747
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males.
Cuchel M; Schaefer EJ; Millar JS; Jones PJ; Dolnikowski GG; Vergani C; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1910-7. PubMed ID: 9351353
[TBL] [Abstract][Full Text] [Related]
13. Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).
Diffenderfer MR; Lamon-Fava S; Marcovina SM; Barrett PH; Lel J; Dolnikowski GG; Berglund L; Schaefer EJ
Metabolism; 2016 Apr; 65(4):381-90. PubMed ID: 26975530
[TBL] [Abstract][Full Text] [Related]
14. Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins.
Vélez-Carrasco W; Lichtenstein AH; Barrett PH; Sun Z; Dolnikowski GG; Welty FK; Schaefer EJ
J Lipid Res; 1999 Sep; 40(9):1695-700. PubMed ID: 10484617
[TBL] [Abstract][Full Text] [Related]
15. The 3H-leucine tracer: its use in kinetic studies of plasma lipoproteins.
Fisher WR; Venkatakrishnan V; Fisher ES; Stacpoole PW; Zech LA
Metabolism; 1997 Mar; 46(3):333-42. PubMed ID: 9054478
[TBL] [Abstract][Full Text] [Related]
16. Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans.
Welty FK; Lichtenstein AH; Barrett PH; Jenner JL; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1807-10. PubMed ID: 10894821
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods.
Ikewaki K; Rader DJ; Schaefer JR; Fairwell T; Zech LA; Brewer HB
J Lipid Res; 1993 Dec; 34(12):2207-15. PubMed ID: 8301239
[TBL] [Abstract][Full Text] [Related]
18. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes.
Parhofer KG; Hugh P; Barrett R; Bier DM; Schonfeld G
J Lipid Res; 1991 Aug; 32(8):1311-23. PubMed ID: 1770313
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of a stable isotopically labeled amino acid into multiple human apolipoproteins.
Patterson BW; Hachey DL; Cook GL; Amann JM; Klein PD
J Lipid Res; 1991 Jul; 32(7):1063-72. PubMed ID: 1940631
[TBL] [Abstract][Full Text] [Related]
20. Intracellular apoA-I and apoB distribution in rat intestine is altered by lipid feeding.
Magun AM; Mish B; Glickman RM
J Lipid Res; 1988 Sep; 29(9):1107-16. PubMed ID: 3141543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
